Skip to main content
British Journal of Cancer logoLink to British Journal of Cancer
. 1977 Sep;36(3):307–312. doi: 10.1038/bjc.1977.194

Assessment of drug sensitivity of human leukaemic myeloblasts. II. The toxic effects of cytosine arabinoside on 125IUdR-labelled human leukaemic myeloblasts in mice.

S T Sonis, R Falcão, I C MacLennan
PMCID: PMC2025424  PMID: 270373

Abstract

Leukaemia cells from the peripheral blood and bone marrow of patients with acute myeloblastic leukaemia were labelled in vitro with [125I]5-iodo-2'-deoxy-uridine (IUdR). The myeloblasts were then injected into groups of mice and the survival of these cells estimated by measuring isotope loss, using whole-body counting. The isotope excretion from mice treated with various doses of cytosine arabinoside (Ara-C) and those not treated with drugs were compared. This comparison showed that the sensitivity of myeloblasts to the drug varies from patient to patient, and in one case was different for myeloblasts from bone marrow and from blood from the same patient. We compare the clinical responses of myeloblasts to Ara-C in 6 patients, who had high peripheral blood myeloblast counts, with the sensitivities of their myeloblasts to Ara-C in mice. This comparison indicates that the assay might be a useful way of predicting the response of leukaemic cells in patients to cytotoxic agents.

Full text

PDF
307

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Crowther D., Beard M. E., Bateman C. J., Sewell R. L. Factors influencing prognosis in adults with acute myelogenous leukaemia. Br J Cancer. 1975 Oct;32(4):456–464. doi: 10.1038/bjc.1975.247. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Falcão R. P., Sonis S., MacLennan I. C., Chassoux D., Davies A. J., Munro T. R. Assessment of drug sensitivity of human leukaemic myeloblasts. I. Labelling human myeloblasts with 125IUdR for survival studies in mice. Br J Cancer. 1977 Sep;36(3):297–306. doi: 10.1038/bjc.1977.193. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. HUGHES W. L., COMMERFORD S. L., GITLIN D., KRUEGER R. C., SCHULTZE B., SHAH V., REILLY P. DEOXYRIBONUCLEIC ACID METABOLISM IN VIVO: I. CELL PROLIFERATION AND DEATH AS MEASURED BY INCORPORATION AND ELIMINATION OF IODODEOXYURIDINE. Fed Proc. 1964 May-Jun;23:640–648. [PubMed] [Google Scholar]
  4. Hofer K. G. In vivo effects of methotrexate. Inhibition of DNA synthesis and cell death in sensitive and resistant L1210 ascites populations. Chemotherapy. 1972;17(1):59–70. doi: 10.1159/000220839. [DOI] [PubMed] [Google Scholar]
  5. Hofer K. G., Rosenoff S., Prensky W., Hughes W. L. Spontaneous and amethopterin-induced death of L1210 leukaemia cells in vivo. Nature. 1969 Feb 8;221(5180):576–577. doi: 10.1038/221576a0. [DOI] [PubMed] [Google Scholar]
  6. Porteous D. D., Munro T. R. The kinetics of the killing of mouse tumour cells in vivo by immune responses. Int J Cancer. 1972 Jul 15;10(1):112–117. doi: 10.1002/ijc.2910100115. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES